{"schema_version":"secwatch.filing_event.v1","accession":"0001214659-25-007204","form_type":"8-K","ticker":"ALZN","cik":"0001677077","company_name":"Alzamend Neuro, Inc.","filed_at":"2025-05-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.306447+00:00","generated_at":"2026-05-22T04:48:05.077365+00:00","sec_items":["5.03","7.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Alzamend Neuro announces 1-for-9 reverse stock split effective May 12 to maintain Nasdaq listing","bullets":["Shares outstanding reduce from ~7,208,591 to ~800,954 at 1-for-9 ratio.","Split effective May 12, 2025; trading symbol remains ALZN with new CUSIP 02262M605.","Reverse split aimed at complying with Nasdaq $1.00 minimum bid price requirement.","No fractional shares issued; holders of fractional shares will receive cash payment.","Par value unchanged at $0.0001 per share; all options/warrants proportionally adjusted."],"urls":{"canonical":"https://secwatch.observer/filing/0001214659-25-007204","json":"https://secwatch.observer/filing/0001214659-25-007204.json","markdown":"https://secwatch.observer/filing/0001214659-25-007204.md","text":"https://secwatch.observer/filing/0001214659-25-007204.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1677077/000121465925007204/0001214659-25-007204-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1677077/000121465925007204/z572538k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T04:48:05.077365+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}